This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.

New Video Resource

Diabetes Canada Clinical Practice Guidelines:
Recommendations for
Continuous Glucose Monitoring (CGM)

Click Here to Watch Now

Featured Conference Update

Latest Research in Diabetes Technology:
Highlights from ATTD 2022

Featured Resource

Continuous Glucose Monitoring:
An Opportunity for Population-Based Diabetes Management

Featured Update

2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes

Featured Payer Update

Non-insured Health Benefits Program Now Covers Dexcom G6
Continuous Glucose Monitoring System for Children and
Adolescents on Intensive Insulin Therapy

Featured Publication

Comparing real-time and intermittently scanned continuous glucose monitoring in adults
with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized
controlled trial [Summary]

Wearable medical technology helps keep employees with diabetes healthy & productive

Wearable medical technology helps keep employees with diabetes healthy & productiveBenefits Canada – 2020 ๐Ÿ